Holsinger Leslie

CIK 00017708211 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001770821

Recent Transactions

17 trades

Tax Payment
Quince Therapeutics, Inc.$QNCX
Common Stock
2022-06-06$2.86/sh−10,920→ 148,080 total
Award
Quince Therapeutics, Inc.$QNCX
Common Stock
2022-03-03+155,500→ 159,000 total
Award
Quince Therapeutics, Inc.$QNCX
Stock option (right to buy)
2022-01-03+125,000→ 125,000 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-12-14−40,000→ 66,794 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-12-14$28.80/sh−1,700→ 41,800 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-12-14$30.15/sh−14,275→ 27,525 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-12-14$30.91/sh−13,200→ 14,325 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-12-14$31.79/sh−9,525→ 1,800 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-12-14$32.59/sh−400→ 4,400 total
Sale
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-12-14$32.59/sh−900→ 3,500 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-12-14$0.27/sh+40,000→ 43,500 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-12-11+100,000→ 100,000 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-12-11+100,000→ 100,000 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-12-10−3,500→ 106,794 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-12-10$0.27/sh+3,500→ 3,500 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-05-14+30,000→ 30,000 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-02-06+100,000→ 100,000 total

Companies

Quince Therapeutics, Inc.
Executive Vice President
$QNCX

Recent Filings

Address

C/O CORTEXYME, INC. 269 EAST GRAND AVE.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov